More about
Non-Hodgin Lymphoma
News
June 13, 2024
2 min read
Save
Armored cells may form ‘an effective strategy’ in lymphoma after CAR-T fails
CHICAGO — Treatment of with an investigational chimeric antigen receptor T-cell therapy showed an acceptable safety profile and produced durable remissions among certain patients with non-Hodgin lymphoma.
News
December 11, 2023
3 min read
Save
Racial, ethnic disparities in mortality risk shown among younger patients with DLBCL
SAN DIEGO — Significant racial and ethnic disparities exist in survival outcomes of adolescent and young adults with diffuse large B-cell lymphoma, according to study findings presented at ASH Annual Meeting and Exposition.